Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Review

Defining, identifying and addressing problematic polypharmacy within multimorbidity in primary care: a scoping review.

Tsang JY, Sperrin M, Blakeman T, et al. Defining, identifying and addressing problematic polypharmacy within multimorbidity in primary care: a scoping review. BMJ Open. 2024;14(5):e081698. doi:10.1136/bmjopen-2023-081698.

Save
Print
June 12, 2024
Tsang JY, Sperrin M, Blakeman T, et al. BMJ Open. 2024;14(5):e081698.
View more articles from the same authors.

Polypharmacy can increase medication complexity and lead to medication errors or adverse drug events (ADEs). This scoping review examined how polypharmacy is defined, identified, and addressed across 157 articles. The authors concluded that there is no consensus definition for polypharmacy. The authors also identified considerable variability in the types of interventions used to address polypharmacy, with studies covering a wide range of aims (e.g., reducing ADEs or patient falls, or improving adherence).

Save
Print
Cite
Citation

Tsang JY, Sperrin M, Blakeman T, et al. Defining, identifying and addressing problematic polypharmacy within multimorbidity in primary care: a scoping review. BMJ Open. 2024;14(5):e081698. doi:10.1136/bmjopen-2023-081698.

Related Resources From the Same Author(s)
Related Resources